BUFFALO, N.Y. — OmniSeq, Inc.®, an innovator in next generation sequencing (NGS) in oncology, today announced the benefits of its OmniSeq Advance® comprehensive genomic and immune profiling assay to detect the presence of rare alterations in the RET gene in the tumors of some patients with non-small cell lung cancer (NSCLC) and thyroid cancer. Those patients eligible for treatment with […]
iGLS Among Labs Chosen by Spanish Health Authorities to Expand SARS-CoV-2 Screening End-to-End Workflow from Extraction through Real-Time PCR Using Fluidigm Microfluidics Technology and Reagents Screening of Critical Populations Under Way, Capacity of Up to 6,000 Tests Per Day on Single Instrument SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with […]
Partnership targets accelerating the commercialization of enzymatic DNA synthesis; Codexis invests cash and protein engineering for equity stake in Molecular Assemblies REDWOOD CITY, Calif. and SAN DIEGO – Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce […]
First-of-its-kind test allows for significant increase in testing capacity NASHVILLE, Tenn. – PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, today announced the company has been selected as an early access partner for the launch of Illumina’s new sequencing-based COVID-19 test, COVIDSeq. COVIDSeq accommodates more […]
MONTREAL – Montreal-based biotechnology provider Galenvs Sciences Inc. “Galenvs”, today announces that the Canadian Federal Government has signed an agreement with Galenvs to supply functionalized magnetic reagents for Coronavirus RNA extraction necessary to enable the COVID-19 testing efforts across Canada. Galenvs is producing magnetic-based reagents specifically designed for Coronavirus RNA extraction methodologies used in all federal research institutions. […]
Quality and Fidelity: New double-stranded DNA fragments are ideal for accelerating research across applications and disciplines CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced the launch of gBlocks™ HiFi Gene Fragments. The industry-leading quality of these double-stranded DNA fragments make them an ideal solution for everything from traditional cloning to the […]
Latest version of innovative enterprise platform represents a leap forward in digitalization, accelerating routine NGS analysis for efficient cell line development, process optimization and biosafety applications Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Selector® 6.0, the latest version of its innovative enterprise […]
Agreement centers on identifying HER2 gene mutations using Oncomine Dx Target Test CARLSBAD, Calif. — Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo Fisher’s next-generation sequencing (NGS)-based Oncomine Dx Target Test. The CDx will be designed to identify non-small cell lung cancer (NSCLC) […]
DURHAM, N.C. — BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it has entered into an exclusive worldwide licensing agreement with St. Jude Children’s Research Hospital, the nation’s leading hospital dedicated to understanding, treating and curing childhood cancer and other life-threatening diseases. BioSkryb will […]
Funding by CVC Credit Partners will support the business’s buy-and-build growth strategy CVC Credit Partners (“CVC Credit”) is pleased to announce that it has provided a $92 million multicurrency first lien credit facility to Calibre Scientific, the life sciences and diagnostics business owned by StoneCalibre. Funding provided by CVC Credit will be used to refinance […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
